Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Novel technique could transform the treatment landscape for brain disorders

The human brain's adaptability to internal and external changes, known as neural plasticity, forms the foundation for understanding cognitive functions like memory and learning, as well as various neurological disorders.

24 Feb 2024

Reevaluating the role of direct oral anticoagulants in cardiovascular treatment

Direct oral anticoagulants (DOACs) are a common treatment for patients with a wide variety of cardiovascular conditions.

23 Feb 2024

Some stroke patients experience more fatigue and daytime sleep

Some people feel worse than others after a stroke. Stroke patients with cognitive and emotional problems tend to experience fatigue more often and sleep more during the day, according to recent research.

23 Feb 2024

Gut microbial metabolite plays a role in exacerbating thrombosis

A gut microbial metabolite called 2-methylbutyrylcarnitine (2MBC) plays a role in exacerbating thrombosis -- the formation of blood clots – researchers report February 23rd in the journal Cell Metabolism.

23 Feb 2024

Sugar coatings on immunoglobulin G directly related to cardiovascular disease risk

When people hear about predicting heart disease, most will think of cholesterol levels. While cholesterol is a major contributor to heart disease, a recent study from Brigham and Women's Hospital, a founding member of Mass General Brigham, found that a glycan biomarker of IgG is also an important predictor for cardiovascular diseases (CVD).

23 Feb 2024

Understanding and addressing neurodevelopmental challenges in congenital heart disease

More than a decade of new knowledge about neurodevelopmental risk in people with congenital heart disease has changed the thinking about who is most at risk and the factors that impact neurological development, learning, emotions and behaviors, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

22 Feb 2024

Machine learning model to determine associations between metabolic syndrome and lactation

Machine learning models to investigate the relationship of lactation with metabolic syndrome risk.

22 Feb 2024

Novel treatment for polycythemia vera shows promise in clinical trial

A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debilitating symptoms in a multi-center clinical trial led by the Icahn School of Medicine at Mount Sinai.

21 Feb 2024

Men with higher area of abdominal muscle have greater risk of cardiac trouble, study shows

Body composition - often expressed as the amount of fat in relation to muscle - is one of the standard predictors of cardiac health.

21 Feb 2024

Study links air pollution with increased Alzheimer's markers

People with higher exposure to traffic-related air pollution were more likely to have high amounts of amyloid plaques in their brains associated with Alzheimer's disease after death, according to a study published in the February 21, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

21 Feb 2024

Raised blood pressure remains the leading risk factor for all-cause and cardiovascular deaths in Australia

Raised blood pressure has been the leading risk factor for death in Australia for the past three decades, according to a study published February 21, 2024, in the open-access journal PLOS ONE led by Alta Schutte and Xiaoyue Xu from The George Institute for Global Health and UNSW, Sydney, with colleagues across Australia.

21 Feb 2024

Study links ultra-processed food consumption with higher cardiovascular risk

Systematic review and meta-analysis revealed a linear relationship between the consumption of ultra-processed foods and an increased risk of cardiovascular events, emphasizing the need for public health initiatives to mitigate this risk.

21 Feb 2024

New mechanism discovered: B cells' contribution to immune tolerance in thymus gland

Immune cells must learn not to attack the body itself. A team of researchers from the Technical University of Munich (TUM) and the Ludwig Maximilian University of Munich (LMU) has discovered a previously unknown mechanism behind this: other immune cells, the B cells, contribute to the "training" of the T cells in the thymus gland.

21 Feb 2024

Study highlights COVID-19's mental health toll on older adults with stroke history

A new longitudinal study from the University of Toronto highlights the substantial mental health toll of the COVID-19 pandemic on older adults with a history of stroke.

21 Feb 2024

Finasteride may offer life-saving benefits beyond hair loss treatment

The drug finasteride, also known as Propecia or Proscar, treats male pattern baldness and enlarged prostate in millions of men worldwide.

20 Feb 2024

Healthy plant-based diets linked to lower risk of obstructive sleep apnea

People who eat a healthy, plant-based diet that is high in vegetables, fruit, whole grains and nuts are less likely to suffer with obstructive sleep apnea (OSA), according to a study published today (Wednesday) in ERJ Open Research.

20 Feb 2024

Study reveals low utilization of PCSK9 inhibitors in high-risk patients

A new study published in Circulation: Cardiovascular Quality and Outcomes from the Family Heart Foundation - a patient-centered research and advocacy nonprofit organization dedicated to improving the lives of families impacted by inherited lipid disorders and LDL-cholesterol - revealed that utilization of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) to reduce low-density lipoprotein cholesterol (LDL-C) remains low among high-risk patients.

20 Feb 2024

Stroke News and Research

Further Reading

Novel technique could transform the treatment landscape for brain disorders

Reevaluating the role of direct oral anticoagulants in cardiovascular treatment

Some stroke patients experience more fatigue and daytime sleep

Gut microbial metabolite plays a role in exacerbating thrombosis

Sugar coatings on immunoglobulin G directly related to cardiovascular disease risk

Understanding and addressing neurodevelopmental challenges in congenital heart disease

Machine learning model to determine associations between metabolic syndrome and lactation

Novel treatment for polycythemia vera shows promise in clinical trial

Men with higher area of abdominal muscle have greater risk of cardiac trouble, study shows

Study links air pollution with increased Alzheimer's markers

Raised blood pressure remains the leading risk factor for all-cause and cardiovascular deaths in Australia

Study links ultra-processed food consumption with higher cardiovascular risk

New mechanism discovered: B cells' contribution to immune tolerance in thymus gland

Study highlights COVID-19's mental health toll on older adults with stroke history

Finasteride may offer life-saving benefits beyond hair loss treatment

Healthy plant-based diets linked to lower risk of obstructive sleep apnea

Study reveals low utilization of PCSK9 inhibitors in high-risk patients

Ultra-sensitive blood test predicts functional outcome in stroke patients

Women reap greater health benefits from exercise than men

Study discovers link between a breakdown product from excess niacin and heart disease

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News